SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is trending due to escalating geopolitical tensions in the Middle East, specifically following reports of US-Israeli strikes on Iran, which is fueling intense community debate about potential oil supply disruptions, particularly through the Strait of Hormuz. Investors are sharply divided between anticipating a significant oil price spike and expecting a 'sell the news' reversal.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund is surging as escalating Middle East tensions, including strikes on oil infrastructure and disruptions to the Strait of Hormuz, fuel community expectations of significant oil price spikes and a massive upward move for the sector.

ProShares Trust - ProShares Ultra Gold 2x Shares

ProShares Ultra Gold

UGL is trending as escalating geopolitical uncertainties and concerns over ongoing fiat currency debasement spur significant safe-haven demand, with the community actively discussing gold's strong upward momentum and the broader precious metals rally.

Codatta

XNY (Codatta) is drawing significant attention for its strong performance and resilience, often showing green metrics even when the broader crypto market faces pullbacks. The community is actively discussing its potential for further breakouts and new highs, driven by its utility in powering AI and decentralized science data projects, alongside recent exchange listings.

The centrifuge token model powers centrifuge, providing the framework needed to run the platform without reliance on a single point of failure, including the centrifuge team or Company, and to accelerate its utility. To accomplish this, centrifuge leverages the cryptoeconomic primitives of a native token called the centrifuge token (cfg), a nominated-proof-of-stake consensus algorithm that employs centrifuge to stake value, rewards for centrifuge adoption, and an on-chain governance mechanism that empowers centrifuge holders to guide the development of centrifuge.

Centrifuge

Centrifuge is trending following the launch of the world's first licensed S&P 500 Index Fund Token, a development hailed by the community as a monumental step for institutional adoption and a significant advancement in tokenizing real-world assets.

Direxion Shares ETF Trust - Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

GUSH is trending amid heightened speculation surrounding escalating Middle East geopolitical tensions and their potential impact on global oil supply routes, with the community actively discussing a significant upward move for oil and gas exploration and production.

Wheaton Precious Metals Corp. is a precious metals streaming company with the quality portfolio of long-life, low-cost assets. Its business model offers investors commodity price leverage and exploration upside but with a much lower risk profile than a traditional mining company. It operates through the following business segments: Gold, Silver, Palladium, Cobalt, and Other. Wheaton was founded by Peter Derek Barnes on December 17, 2004 and is headquartered in Vancouver, Canada.

Wheaton Precious Metals Corp

Wheaton Precious Metals is gaining attention amid soaring gold prices reaching all-time highs and silver breaking multi-decade resistance, amplifying interest in its asset-light streaming model. The community is discussing recent strong earnings, a robust balance sheet, and a series of analyst target increases, though some express skepticism about its short-term price movements relative to the broader precious metals sector.

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc

Aardvark Therapeutics is facing intense scrutiny and negative sentiment after voluntarily pausing its Phase 3 HERO trial for ARD-101 due to reversible cardiac safety signals observed in high-dose studies. The community is expressing significant concern about the drug's future and the company's prospects in the competitive Prader-Willi Syndrome treatment landscape.

OR Royalties, Inc. engages in the acquisition, mining, and exploration of precious metals, streams, and other royalties. It holds interests in the Canadian Malartic mine. The company was founded on April 29, 2014 and is headquartered in Montreal, Canada.

OR Royalties Inc.

Osisko Gold Royalties Ltd

Osisko Gold Royalties is attracting significant community interest following its joint acquisition of a major gold stream on SolGold's Cascabel project and the emergence of activist investor Elliott Management as a large stakeholder. This news, combined with robust preliminary Q2 results showcasing record cash margins, reinforces bullish sentiment for the stable gold royalty player.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

The defense community is buzzing about Kratos Defense & Security Solutions, navigating a recent substantial stock offering against a wave of new contracts for its leading drone and hypersonic systems. Investors are keenly focused on the company's pivotal role in evolving global defense priorities and the anticipated surge in military spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Monashee Investment Management LLC Has $4.38 Million Stake in Compass Therapeutics, Inc. $CMPX

Monashee Investment Management LLC grew its position in Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) by 657.6% in the third quarter, according to its most recent Form 13F filing with the...

Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Moderate Buy" by Analysts

Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the fourteen ratings firms that are currently covering the...

Compass Therapeutics (CMPX) to Release Quarterly Earnings on Thursday

Compass Therapeutics (NASDAQ:CMPX) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?

Here is how Compass Therapeutics, Inc. (CMPX) and Ekso Bionics (EKSO) have performed compared to their sector so far this year.

Compass Therapeutics (NASDAQ:CMPX) Raised to "Hold" at Wall Street Zen

Wall Street Zen upgraded shares of Compass Therapeutics from a "sell" rating to a "hold" rating in a research note on Monday...

Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Craig Hallum

Craig Hallum began coverage on shares of Compass Therapeutics in a report on Friday. They set a "buy" rating and a $15.00 target price for the company...

Compass Therapeutics (NASDAQ:CMPX) Cut to "Sell" at Wall Street Zen

Wall Street Zen lowered shares of Compass Therapeutics from a "hold" rating to a "sell" rating in a research report on Sunday...

Compass Therapeutics (NASDAQ:CMPX) Sets New 1-Year High - Here's What Happened

Compass Therapeutics (NASDAQ:CMPX) Hits New 1-Year High - What's Next...

Wall Street Zen Upgrades Compass Therapeutics (NASDAQ:CMPX) to "Hold"

Wall Street Zen raised Compass Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...

Are Medical Stocks Lagging  ResMed (RMD) This Year?

Here is how ResMed (RMD) and Compass Therapeutics, Inc. (CMPX) have performed compared to their sector so far this year.

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Compass Therapeutics Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

CMPX
Compass Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CMPX News

CMPXCompass Therapeutics Inc